Cellectar Biosciences, Inc. — Director's Dealing 2014

Sep 9, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2014-08-27

Reporting Person: Genn John Patrick (VP of Business Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-27	Stock purchase warrant (right to buy)	$4.68	P	3000	Acquired	2019-08-20	Common Stock (3000)	Direct
2014-08-28	Stock purchase warrant (right to buy)	$4.68	P	22000	Acquired	2019-08-20	Common Stock (22000)	Direct
2014-08-29	Stock purchase warrant (right to buy)	$4.68	P	15000	Acquired	2019-08-20	Common Stock (15000)	Direct
2014-09-08	Stock purchase warrant (right to buy)	$4.68	P	10000	Acquired	2019-08-20	Common Stock (10000)	Direct